Uterine Atony Clinical Trial
Official title:
Exploration and Determination of Genomic Markers Predictive of Uterine Atony
The primary objective of this study is to determine whether there are markers in the tissue of atonic uteri, and in the patients' plasma that would help identify patients likely to suffer postpartum hemorrhage due to uterine atony. We also will attempt to identify the cause(s) of uterine atony that might suggest mechanisms to prevent and manage it.
Patient will be recruited from those admitted to our Labor and Delivery unit. Ten women will be the control subjects, and these will be selected from patients who are admitted for scheduled cesarean delivery. Ten women will be selected from women who develop uterine atony either following cesarean delivery, or postpartum patients who delivered vaginally but subsequently required surgical management of uterine atony (hysterectomy or uterine saving surgery). From each patient a small amount of uterine muscle will be excised and placed in a fixative, preservative transport medium. Ten cubic centimeters of blood will be drawn from each patient to accompany the tissue. The tissue and blood will be processed and analyzed to identify differences in the tissue and plasma of messenger RNA, micro RNA, long non-coding RNA, and DNA methylation in normal and atonic uterine patients. Statistical analysis of these markers will be performed to determine whether there are significant differences in their expression. It is hoped that differences will be discovered that may be used diagnostically to predict uterine atony, and differences that may suggest the etiology of uterine atony. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT02910115 -
Cooling the Uterus in C-section After Dysfunctional Labor
|
N/A | |
| Withdrawn |
NCT02410655 -
An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery
|
Phase 4 | |
| Completed |
NCT00790062 -
Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT
|
Phase 4 | |
| Recruiting |
NCT01579201 -
ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery
|
Phase 4 | |
| Completed |
NCT03867383 -
Calcium Chloride for Prevention of Uterine Atony During Cesarean
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03584854 -
Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial
|
Phase 4 | |
| Completed |
NCT02780245 -
Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section
|
Phase 4 | |
| Completed |
NCT00785395 -
Up-Down Oxytocin Infusion
|
Phase 4 | |
| Withdrawn |
NCT03303235 -
Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections
|
Early Phase 1 | |
| Completed |
NCT02229513 -
Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage
|
N/A | |
| Not yet recruiting |
NCT06192836 -
Placental Removal Method And Uterine Massage On Preventing Postpartum Hemorrhage
|
||
| Withdrawn |
NCT01252342 -
Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery?
|
Phase 4 | |
| Completed |
NCT04690153 -
Novel Approach of Hayman Uterine Compression Sutures for Management of Severe Atonic Postpartum Hemorrhage: Three Vertical Sutures
|
||
| Completed |
NCT05027048 -
Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery
|
Phase 3 | |
| Completed |
NCT01630187 -
Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section
|
Phase 4 | |
| Completed |
NCT01549223 -
Oxytocin And Uterotonic Agent Use For Cesarean Delivery
|
Phase 4 |